Simplify Logo

Full-Time

Director/Senior Director

Clinical Science

Confirmed live in the last 24 hours

Coherus BioSciences

Coherus BioSciences

201-500 employees

Develops and commercializes biosimilars for healthcare

Biotechnology
Healthcare

Compensation Overview

$190k - $260kAnnually

Senior, Expert

San Carlos, CA, USA

Category
Physicians & Surgeons
Medical, Clinical & Veterinary
Required Skills
Data Analysis
Requirements
  • PhD degree in health science field, PharmD, MD or non-US equivalent, or other relevant advanced degree in a health science field.
  • Minimum 7+ years of experience for Director, 12+ years of experience for Senior Director at a pharmaceutical, CRO or biotechnology company as a clinical scientist or related role.
  • Experience in oncology or oncology immunotherapy clinical trials preferred.
  • Early stage drug development experience required.
  • Experience with data analysis and interpretation.
  • Thorough understanding of the drug development process.
  • Broad understanding of functional areas of drug development, including preclinical, regulatory, pharmacovigilance, drug supply, data sciences (data management, biostatistics, programming), and clinical operations (including site selection, study start-up, study conduct, and finalization).
  • Demonstrated ability to communicate and write clearly, concisely, and effectively.
  • Ability to understand, interpret and communicate clinical information including literature reviews, competitive intelligence, and changing treatment paradigms in order to apply knowledge to support a robust clinical development strategy.
  • Understanding of trial design and statistics.
  • Ability to interpret, analyze, and present clinical data.
  • Well-organized: ability to prioritize tasks with a successful track record of managing multiple projects in a fast-paced and deadline-driven environment.
  • Impeccable attention to detail.
Responsibilities
  • Partner with cross-functional program team members and key R&D stakeholders to contribute to the clinical strategy and creation of clinical development plans for one or more candidate clinical drug products.
  • Provide clinical support for clinical study conduct, including operational feasibility, data management, communication plans, safety and medical monitoring, preparation of meeting materials and study updates.
  • Perform medical and safety/efficacy data reviews. Prepare and communicate clear overviews of trial results.
  • Identify issues related to study conduct and/or subject safety. Provide preliminary assessments and recommendations and collaborate with the clinical team to develop solutions ensure resolution.
  • Provide organizational support for data review committees including operationalizing the charter, preparing updates and data reviews, development of meeting materials and data reports and execution of meetings.
  • Author protocols and contribute to authoring of clinical study reports, IBs, ICFs, training documents, and other clinical and regulatory documents.
  • Interact with internal and external stakeholders (study sites, vendors, KOLs, etc.) in support of program-level strategy as well as clinical trial objectives.
  • Act as recognized clinical expert for assigned programs.
  • Lead development of abstracts, posters, and content for scientific meetings, conferences and publications.

Coherus BioSciences develops and sells biosimilars, which are highly similar versions of approved biologic medicines used to treat various diseases. These biosimilars are designed to be as effective and safe as the original products but are offered at a lower cost, making them more affordable for patients and healthcare systems. The company focuses on research, development, and commercialization of these products, ensuring they meet strict regulatory standards for quality and efficacy. Coherus aims to improve patient lives by expanding access to essential biologic treatments, helping to reduce healthcare costs. Their business model allows them to generate revenue through the sale of these cost-effective alternatives, giving them a competitive advantage in the biopharmaceutical market.

Company Stage

IPO

Total Funding

$1.2B

Headquarters

Redwood City, California

Founded

2010

Growth & Insights
Headcount

6 month growth

-6%

1 year growth

-11%

2 year growth

-20%
Simplify Jobs

Simplify's Take

What believers are saying

  • The launch of innovative products like the Udenyca wearable injector device demonstrates Coherus' commitment to improving patient care and expanding market share.
  • The divestiture of non-core assets like the Lucentis biosimilar allows Coherus to focus resources on its core oncology franchise, potentially driving higher growth and profitability.
  • Strategic board appointments and clinical collaborations position Coherus for sustained innovation and leadership in the biosimilar market.

What critics are saying

  • The competitive landscape for biosimilars is intense, requiring continuous innovation and cost management to maintain market position.
  • Frequent restructuring and staff reductions, as seen with the recent 30% cut, could impact employee morale and operational efficiency.

What makes Coherus BioSciences unique

  • Coherus BioSciences focuses exclusively on biosimilars, providing cost-effective alternatives to expensive biologic medicines, unlike competitors who may offer a broader range of pharmaceuticals.
  • Their rigorous approval process ensures high standards of quality and efficacy, setting them apart in a market where regulatory compliance is critical.
  • Strategic collaborations, such as with the Cancer Research Institute, enhance their research capabilities and expand their treatment options.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Competitive base salary

Target bonus based on performance

stock options

Medical, dental, & vision coverage

PTO

401(k) plan

FSA